KR20200013103A - 데옥시콜린산 및 그의 염들의 제형물들 - Google Patents

데옥시콜린산 및 그의 염들의 제형물들 Download PDF

Info

Publication number
KR20200013103A
KR20200013103A KR1020207002722A KR20207002722A KR20200013103A KR 20200013103 A KR20200013103 A KR 20200013103A KR 1020207002722 A KR1020207002722 A KR 1020207002722A KR 20207002722 A KR20207002722 A KR 20207002722A KR 20200013103 A KR20200013103 A KR 20200013103A
Authority
KR
South Korea
Prior art keywords
composition
deoxycholic acid
precipitation
water
solution
Prior art date
Application number
KR1020207002722A
Other languages
English (en)
Korean (ko)
Inventor
로버트 에밀 호지
제프리 더글라스 웹스터
로버트 엠. 모리어티
Original Assignee
알레간 세일즈, 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45569726&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20200013103(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 알레간 세일즈, 엘엘씨 filed Critical 알레간 세일즈, 엘엘씨
Publication of KR20200013103A publication Critical patent/KR20200013103A/ko

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
KR1020207002722A 2011-08-23 2011-08-23 데옥시콜린산 및 그의 염들의 제형물들 KR20200013103A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/048806 WO2013028177A1 (en) 2011-08-23 2011-08-23 Formulations of deoxycholic acid and salts thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020197030233A Division KR102073536B1 (ko) 2011-08-23 2011-08-23 데옥시콜린산 및 그의 염들의 제형물들

Publications (1)

Publication Number Publication Date
KR20200013103A true KR20200013103A (ko) 2020-02-05

Family

ID=45569726

Family Applications (5)

Application Number Title Priority Date Filing Date
KR1020207002722A KR20200013103A (ko) 2011-08-23 2011-08-23 데옥시콜린산 및 그의 염들의 제형물들
KR1020197030233A KR102073536B1 (ko) 2011-08-23 2011-08-23 데옥시콜린산 및 그의 염들의 제형물들
KR1020177016779A KR101919269B1 (ko) 2011-08-23 2011-08-23 데옥시콜린산 및 그의 염들의 제형물들
KR1020187032491A KR102034606B1 (ko) 2011-08-23 2011-08-23 데옥시콜린산 및 그의 염들의 제형물들
KR1020147006855A KR101751585B1 (ko) 2011-08-23 2011-08-23 데옥시콜린산 및 그의 염들의 제형물들

Family Applications After (4)

Application Number Title Priority Date Filing Date
KR1020197030233A KR102073536B1 (ko) 2011-08-23 2011-08-23 데옥시콜린산 및 그의 염들의 제형물들
KR1020177016779A KR101919269B1 (ko) 2011-08-23 2011-08-23 데옥시콜린산 및 그의 염들의 제형물들
KR1020187032491A KR102034606B1 (ko) 2011-08-23 2011-08-23 데옥시콜린산 및 그의 염들의 제형물들
KR1020147006855A KR101751585B1 (ko) 2011-08-23 2011-08-23 데옥시콜린산 및 그의 염들의 제형물들

Country Status (18)

Country Link
JP (1) JP5919597B2 (ru)
KR (5) KR20200013103A (ru)
CN (3) CN103826608A (ru)
AU (3) AU2011375432B2 (ru)
BR (1) BR112014000547B1 (ru)
CA (1) CA2842177C (ru)
CR (1) CR20140053A (ru)
EA (1) EA029305B1 (ru)
IL (1) IL230547A (ru)
IN (1) IN2014CN02188A (ru)
MX (1) MX350390B (ru)
MY (1) MY184277A (ru)
NZ (1) NZ620040A (ru)
PH (1) PH12016501175A1 (ru)
SG (1) SG2014013205A (ru)
UA (1) UA113522C2 (ru)
WO (1) WO2013028177A1 (ru)
ZA (1) ZA201401027B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
MX2018005628A (es) * 2015-11-04 2018-08-01 Kythera Biopharmaceuticals Inc Tratamientos de grasa acumulada con acido desoxicolico y sales del mismo.
US20180078621A1 (en) * 2016-09-22 2018-03-22 Kyoung Lack Lee Composition for hypotonic lipolysis and manufacturing method thereof
KR101841193B1 (ko) * 2016-09-22 2018-03-22 이경락 저장성 지방 분해 조성물 및 그의 제조 방법
WO2019203511A1 (ko) * 2018-04-16 2019-10-24 주식회사 펜믹스 데옥시콜릭산을 포함하는 약학 조성물
KR102172439B1 (ko) 2018-12-05 2020-10-30 송미희 지방 분해용 조성물 및 이를 포함하는 주사제 조성물
KR102064864B1 (ko) 2019-02-08 2020-01-10 (주)제테마 국소 주사용 조성물
KR102111346B1 (ko) 2019-08-20 2020-05-22 아영창 침전으로부터 안정한 소듐디옥시콜레이트를 포함하는 수용액상 조성물
KR20220026068A (ko) 2020-08-25 2022-03-04 강명범 지방 분해용 주사제 조성물
CN116617160A (zh) * 2023-07-25 2023-08-22 山东则正医药技术有限公司 水性混悬液及制备方法、冻干粉及应用、脂肪消减注射剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754709B1 (fr) 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
JP4790123B2 (ja) * 1998-07-24 2011-10-12 ヨー、セオ、ホン 胆汁酸を有する透明水溶液型製剤の調剤
US6417179B1 (en) * 1998-10-13 2002-07-09 Craig G. Burkhart Ear wax solution
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
DE10361067A1 (de) * 2003-12-22 2005-07-14 Aventis Pharma Deutschland Gmbh Medikamentöse Lipolyse von Fettansammlungen
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US7622130B2 (en) 2004-05-19 2009-11-24 Los Angeles Biomedical Research Institute at Harbor UCLA-Medical Center Methods and compositions for the non-surgical removal of fat
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20090317376A1 (en) 2005-06-06 2009-12-24 Georgetown University Medical School Compositions And Methods For Lipo Modeling
TW201011755A (en) 2008-09-10 2010-03-16 Skymedi Corp Flash memory system and its data recovery method
JP5420946B2 (ja) * 2009-03-23 2014-02-19 富士フイルム株式会社 胆汁酸を含むミノキシジル水性組成物
EP2645099A1 (en) * 2012-03-30 2013-10-02 Phares Pharmaceutical Research N.V. Biorelevant compositions

Also Published As

Publication number Publication date
MX350390B (es) 2017-09-06
CR20140053A (es) 2014-06-12
KR20170075016A (ko) 2017-06-30
EA029305B1 (ru) 2018-03-30
AU2011375432B2 (en) 2016-02-04
IL230547A0 (en) 2014-03-31
KR102073536B1 (ko) 2020-02-04
CN103826608A (zh) 2014-05-28
KR20190119677A (ko) 2019-10-22
IN2014CN02188A (ru) 2015-05-29
AU2016202661B2 (en) 2018-02-22
KR20150000448A (ko) 2015-01-02
CA2842177A1 (en) 2013-02-28
JP2014524467A (ja) 2014-09-22
NZ620040A (en) 2016-06-24
MY184277A (en) 2021-03-30
AU2018202807A1 (en) 2018-05-10
KR101751585B1 (ko) 2017-06-27
WO2013028177A1 (en) 2013-02-28
SG2014013205A (en) 2014-05-29
PH12016501175B1 (en) 2017-12-11
BR112014000547A2 (pt) 2017-02-14
EA201490175A1 (ru) 2014-06-30
MX2014001495A (es) 2014-04-25
BR112014000547B1 (pt) 2021-11-09
KR102034606B1 (ko) 2019-10-22
CA2842177C (en) 2016-07-19
AU2011375432A1 (en) 2014-02-06
KR20180123734A (ko) 2018-11-19
UA113522C2 (xx) 2017-02-10
IL230547A (en) 2017-02-28
AU2016202661A1 (en) 2016-05-19
PH12016501175A1 (en) 2017-12-11
AU2018202807B2 (en) 2020-01-16
KR101919269B1 (ko) 2018-11-15
JP5919597B2 (ja) 2016-05-18
CN108743522A (zh) 2018-11-06
ZA201401027B (en) 2017-09-27
CN108619089A (zh) 2018-10-09

Similar Documents

Publication Publication Date Title
US20210252021A1 (en) Formulations of deoxycholic acid and salts thereof
KR102073536B1 (ko) 데옥시콜린산 및 그의 염들의 제형물들
US11179404B2 (en) Formulations of deoxycholic acid and salts thereof
US20170119794A1 (en) Treatments of accumulated fat with deoxycholic acid and salts thereof
EP3305298B1 (en) Formulations of deoxycholic acid and salts thereof
JP6219430B2 (ja) デオキシコール酸およびその塩類の製剤
JP6594486B2 (ja) デオキシコール酸およびその塩類の製剤
JP6356329B2 (ja) デオキシコール酸およびその塩類の製剤
EA034320B1 (ru) Композиции дезоксихолата натрия

Legal Events

Date Code Title Description
A107 Divisional application of patent
E902 Notification of reason for refusal
E601 Decision to refuse application